Education Forum IX: TILs, TCRs, CAR T-Cells and Immune Checkpoint Inhibitors in Gynecologic Cancer Care, An Update

Education Forum

Moderators:
Oliver Dorigo, MD, Stanford Hospital and Clinics, Stanford, CA
Kathleen Moore, MD, University of Oklahoma Medical Center, Oklahoma City, OK

Description: This session will focus on immunotherapies beyond immune checkpoint inhibition, including CAR T cells, TIL and vaccine therapies.

Location: Kalakaua A

Top